Domenico D'Amario retweeted
Fast-track approach for SGLT2-I in patients with ACS 🏎️
#EHJPharmacotherapy 💊
@EditorEHJCVP 👨💼
@ESC_Journals @escardio 📚
Safety and efficacy of early initiation of #SGLT2i after #ACS. An updated meta-analysis just published in #EHJPharmacotherapy bit.ly/3Z5K1G3 @EditorEHJCVP @FeliceGragnano @LaboranteRenzo @DDamario @GianluSava @CardioNovara
Domenico D'Amario retweeted
Safety and efficacy of early initiation of #SGLT2i after #ACS. An updated meta-analysis just published in #EHJPharmacotherapy bit.ly/3Z5K1G3 @EditorEHJCVP @FeliceGragnano @LaboranteRenzo @DDamario @GianluSava @CardioNovara
Domenico D'Amario retweeted
#Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in patients undergoing #PCI: the TAPER-S randomised trial bit.ly/47VjbkP
@AgewallStefan @FeliceGragnano @DDamario @ItaloPorto2 #EHJPharmacotherapy #ESCYoung
Domenico D'Amario retweeted
In this observational study, @DDamario @DanieleRodolico et al highlight how many patients with new HFrEF do not receive the 4 pillars of GDMT.
Their data suggests those on more classes of GDMT at hospital discharge may have better outcomes. #AHAJournals ahajrnls.org/3Ovj3Sd
Domenico D'Amario retweeted
#HeartFailure2023 comes to the end.
📌We presented data from the Gemelli HF Datamart supporting initiation of 4 pillars at discharge.
🌟Proud also of our work on doses and outcomes, selected among the “Highlights”.
Thanks to #HFA_ESC for these amazing days! – at Prague, Czech Republic
Domenico D'Amario retweeted
Take home message for 2023: be careful of adenosine! @LaboranteRenzo @Emiliano_Bi2 @AttilioRestivo @MattiaGalli10 @AndreaZito66 @Gprinci19 @DanieleRodolico @DDamario @ehj_ed
Domenico D'Amario retweeted
#RCM-Special Issue: Antiplatelet Therapy in Cardiovascular Disease (2/5)
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
@MattiaGalli10 @LaboranteRenzo @RoccoVergallo @BURZOTTA_F @ehj_ed @DDamario
#PCI #Bleeding
Full text
imrpress.com/journal/RCM/23/…
Domenico D'Amario retweeted
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis, by Galli et al
sciencedirect.com/science/ar…
@MattiaGalli10 @DFCapodanno @DDamario @ItaloPorto2 @BURZOTTA_F @JEscaned @ehj_ed @IJCardio
Sick and almost tired about Twitter? Already 11 years… #IlMioAnniversarioDiTwitter
6
Domenico D'Amario retweeted
ECPELLA versus #ECMO in #CardiogenicShock – do the potential benefits of this unloading strategy outweigh the increased complications? academic.oup.com/ehjqcco/adv…
#EHJQCCO #CathLab @cpgale3 @diogoasantosfer
Domenico D'Amario retweeted
Il massiccio della Maiella conta oltre 60 cime che superano i 2000 metri di altezza. Tra queste il Monte Amaro che, con i suoi 2.793 m s.l.m., è la vetta più alta, la seconda di tutto l'Appennino dopo il Corno Grande del Gran Sasso d'Italia.
👉 https://teapawt.net/t.co/K5f2sZJgMU
#Abruzzo
Domenico D'Amario retweeted
Deeply pleased and honored to receive the recognition of best oral presentation of the 43rd Italian Society of Interventional Cardiology congress @sicigise
Deep thanks to my mentor and PI of the study @DDamario and all RIALTO members. #interventionalcardiology #myocardialbridge
Domenico D'Amario retweeted
Fantastic session discussing the importance and the diagnostic and therapeutic options for INOCA patients. @sicigise #gise2022 @InocaInternati1 @Hragy @mmamas1973
Domenico D'Amario retweeted
Replying to @DDamario
@DDamario presenting talk around microvascular disease and diagnostic pathways -diagnotic workup of inoca needs invasive mx- important role of ACh #GISE @gbiondizoccai @alaide_chief @MariaGi31609461 @VijayKunadian @valeriaparadies @MinnowWalsh @cardioPCImom @drsonyaburgess
Domenico D'Amario retweeted
How to prevent bleeding in patients undergoing PCI?
https://teapawt.net/t.co/B5ee69ZxUe
Domenico D'Amario retweeted
Molto importante da tutti i punti di vista l'intervento di @DDamario che ha come tema il progetto di #openinnovation #AI Azimuth, sullo scompenso cardiaco. #digitalhealth
@MakerFaireRome
live ▶️https://teapawt.net/t.co/VyUl45DnRs
#MFR2022 #MakerFaireRome #branded
Domenico D'Amario retweeted
#ESC_HFA clinical trial course in #HF ongoing in the beautiful Sorrento. Outstanding lectures from worldwide experts #Cardiotwitter @GianluSava @GMCRosano @_antocannata
Domenico D'Amario retweeted
#RCM - Vol. 23 No. 8
💥Review
Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
@MattiaGalli10 @LaboranteRenzo @RoccoVergallo @BURZOTTA_F @ehj_ed @DDamario
#Bleeding #PCI #Complications #antithrombotic therapy
Full Text:
imrpress.com/journal/RCM/23/…
AZIMUTH is our new solution to help patients suffering from heart failure: a new model of care co-designed and co-developed by doctors, patients, industrial and technological partners! linkedin.com/posts/domenico-…










































